Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ingenie Bio
Unknowningeniebio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Ingenie Bio is an active AI-driven consultancy specializing in biomolecular design for peptide, protein, and small molecule discovery. The company leverages artificial intelligence and advanced statistics to support drug discovery campaigns targeting a range of biologically relevant proteins and disease areas. It collaborates with academic groups, national research centers, and biotechnology companies.
- Therapeutic areas
- OncologyEndocrinologyNeurologyInfectious Diseases
- Modalities
- PeptidesProteinsSmall molecule
- Industry
- Drug Discovery Services
02
Partnerships
Collaborates with academic groups, national research centers, public-private partnerships
Beyond the preview
Go deeper on Ingenie Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ingenie Bio.